In addition, POM-1 treatment induced the expansion of cDC1 in the TME in a mouse bladder cancer model, while Batf3-/- cDC1 -deficient mice failed to respond to POM-1 treatment [101]. The gene discussed is MPPE1; the disease is urinary bladder carcinoma.